CU Anschutz Researcher Highlights Liquid Biopsy Breakthrough for Lung Cancer Treatment

CU Anschutz Cancer Center’s Tejas Patil, MD,  co-led new research showing that a liquid biopsy can reliably predict chemo-immunotherapy benefit in advanced lung cancer.